Sercan Karabulut | Health Professions | Best Scholar Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Sercan Karabulut | Health Professions | Best Scholar Award

Akdeniz University School of Medicine | Turkey

Dr. Sercan Karabulut is an accomplished psychiatrist and academic currently serving at the Akdeniz University School of Medicine, Department of Psychiatry, Antalya, Turkey. He earned his Doctor of Medicine (MD) and completed his Psychiatry Residency at the İstanbul Medicine Faculty, where his scientific interest in the neurobiological mechanisms underlying mental disorders was first cultivated. Over the past decade, he has developed an exceptional academic and clinical career across leading institutions, including Antalya Atatürk State Hospital and Van Bölge Research and Training Hospital, focusing on the diagnosis, treatment, and prevention of psychiatric and substance use disorders. His primary research interests encompass addiction psychiatry, psychotic and mood disorders, neuroinflammation, and methamphetamine-related psychopathology, with a special focus on cognitive impairment and gender-based differences in substance use. Dr. Sercan Karabulut has authored 18 scientific publications, accumulating 195 citations from 193 documents and maintaining an h-index of 5, as indexed in Scopus (ID: 56073897200). His works have appeared in prominent journals, including Acta Neuropsychiatrica, Turkish Journal of Psychiatry, Journal of Drug Issues, and Alpha Psychiatry. Notable studies such as Inflammation and Neurodegeneration in Bipolar Disorder (2019) and Frequency of Methamphetamine Use (2024) have been widely cited and advanced the understanding of neuropsychiatric pathophysiology.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

  1. Karabulut, S., Uzar Uçkun, S., & Genç, H. (2025, October). One year follow-up study of patients with opioid use disorder after inpatient detoxification: Predictors of treatment retention and abstinence. Psychiatry Research. https://doi.org/10.1016/j.psychres.2025.116765

  2. Erdoğan, A., Karabulut, S., Coşkun, M. N., & Tosun, O. (2025, October). Clinical factors associated with craving in patients with opioid use disorder receiving buprenorphine-naloxone maintenance therapy. Journal of Substance Use. https://doi.org/10.1080/14659891.2025.2568066

  3. Bilici, R., Ergelen Yalçın, M., Karabulut, S., & Arpacioglu, S. (2025, September). Validity and reliability study of the Turkish version of the Addiction Severity Index. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 38, 180–186. https://doi.org/10.14744/DAJPNS.2025.00289

  4. Düzgün, M., Erdoğan, A., Karabulut, S., & Şafak, E. (2025, August). The impact of smartphone addiction and social media addiction on traffic safety. Journal of Public Health. https://doi.org/10.1007/s10389-025-02578-y

  5. Karabulut, S., & Uzar Uçkun, S. (2025, June). The association between Theory of Mind, psychopathic traits, borderline personality traits and the severity of substance use disorder in women: A comparative analysis. Alpha Psychiatry, 26(3), 44175. https://doi.org/10.31083/AP44175

 

Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Published on by Forensic Scientist

Mr. Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Institute of Legal Medicine and Forensic Sciences of Valencia | Spain

Mr. Alfonso Colorado Casado de Amezúa is a highly respected forensic physician whose career demonstrates a profound commitment to advancing forensic science, medico-legal education, and public communication of specialized knowledge. Currently serving as Director of the Institute of Legal Medicine and Forensic Sciences of Valencia, he has built a distinguished professional record over more than fifteen years, holding key roles across Spain in Catalonia, Albacete, Cuenca, Guadalajara, and Valencia. His leadership has been pivotal in forensic pathology and disaster victim identification, where he has developed and applied protocols for managing mass casualty events with precision and compassion. Alongside his clinical and administrative responsibilities, Mr. Alfonso Colorado Casado de Amezúa has played a central role in training the next generation of forensic professionals. As adjunct professor at the University CEU-Cardenal Herrera in Valencia and Castellón, and as lecturer in numerous specialized courses for forensic doctors, law enforcement, and emergency response teams, he has demonstrated an exceptional ability to communicate complex forensic concepts with clarity and authority. His scientific contributions, including publications in the Revista Española de Medicina Legal and CorSalud, have provided valuable insights into sudden cardiac death and forensic practices in disaster contexts, strengthening both research and applied forensic work. As organizer and speaker in national training programs, he has further enhanced the visibility of forensic medicine and ensured the dissemination of best practices across Spain. By uniting research, practice, and communication, Mr. Colorado embodies the mission of forensic science to serve justice and society, making him an outstanding nominee for the Forensic Science Communication Award.

Profile: ORCID

Featured Publications

Colorado Casado de Amezúa, A., Garrido-Lestache López-Belmonte, E., & Giner Blasco, J. (2025). Medical forensic response during the flood in Valencia (Spain), October 29th, 2024 [Actuación médico-forense durante la riada en Valencia (España) el 29 de octubre de 2024]. Revista Española de Medicina Legal. Advance online publication.

Colorado, A., & Fernández Bayón, J. (2009). Síndrome de Loeys-Dietz. Diagnóstico diferencial en muerte súbita por disección aórtica. Revista Española de Medicina Legal, 35(2), 67–71.

Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Chaoyang Hospital | China

Mr. Zhechun Wu is a resident physician in the Department of Urology at Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, who has established himself as an emerging clinician–scientist combining medical training with impactful research. He earned his Bachelor of Science degree from Capital Medical University and is currently advancing his clinical expertise through residency while contributing to translational oncology research. His work is focused on prostate cancer, with particular emphasis on identifying therapeutic targets that regulate tumor immunity, a critical area for developing next-generation treatment strategies. Mr. Zhechun Wu has published in reputable international journals, including a recent article in Investigational New Drugs that explored drug targets modulating tumor immune response, a study that has already been cited in related scholarly work, reflecting its scientific significance. His projects are supported by competitive funding from the National Natural Science Foundation of China  and the Beijing Natural Science Foundation, highlighting his ability to secure prestigious grants and deliver research with clinical and academic value. Alongside research, his clinical practice in urology, oncology, and kidney transplantation strengthens his understanding of patient-centered challenges, allowing him to align laboratory findings with real-world medical needs. This dual role as physician and researcher equips him to contribute to both advancing cancer therapeutics and improving clinical outcomes, establishing a foundation for future leadership in medical innovation and academic research.

Profile: ORCID

Featured Publications

Zhang, Y., Qiu, X., Wu, Z., Li, Y., Shen, X., Wu, J., Cao, P., Sun, Z., & Wang, W. (2025). Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: Insights from multi-omics approaches and identification of potential therapeutic targets. Environmental Research, 121966.

Wu, Z., Li, S., Li, Y., Wang, Z., & Wang, W. (2025). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology, 16, 98.

Wu, Z. (2025). Higher sexual frequency correlated with lowered PSA complex levels in U.S. men over 40 and without prostate conditions: A nationwide cross-sectional study. The Journal of Sexual Medicine.